Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ReRad III. Pencil Beam Proton Therapy for Recurrences in Anal Cancer Patients Previously Treated With Radiotherapy

NCT05055635 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT05055635
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05055635 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ReRad III. Pencil Beam Proton Therapy for Recurrences in Anal Cancer Patients Previously Treated With Radiotherapy
Lead sponsor
University of Aarhus
Phase
Phase 2
Overall status
Recruiting
Start date
July 7, 2021
Completion date
July 6, 2030
Enrollment
55 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anal cancer, recurrent anal cancer